‘No one quite like her’: meet the female colleagues who inspire these award-winning women in science
To mark International Women’s Day, Nature asked winners of its awards programmes to nominate a colleague who brings out the best in them.
‘No one quite like her’: meet the female colleagues who inspire these award-winning women in science
To mark International Women’s Day, Nature asked winners of its awards programmes to nominate a colleague who brings out the best in them.
www.nature.com/articles/d41...
03.03.2026 05:47 —
👍 76
🔁 20
💬 2
📌 1
That looks amazing! I'm away this week, missed it.
02.03.2026 09:56 —
👍 1
🔁 0
💬 1
📌 0
The updated International Committee of Medical Journal Editors (ICMJE) recommendations suggest what journals can do to ensure appropriate use of AI, but real compliance starts in the institutions where researchers learn their habits. buff.ly/DVxxIJZ
27.02.2026 08:02 —
👍 0
🔁 1
💬 0
📌 0
Anyway, thanks for the paper. Very interesting!
25.02.2026 12:08 —
👍 1
🔁 0
💬 0
📌 0
Less screening leads to longer TATs. Also not sure whether one can directly compare initial desk decision with peer review decisions. For selective journals can former can be done quite reliably. Second is not only about accept/reject, more so about improving article.
25.02.2026 12:08 —
👍 0
🔁 0
💬 1
📌 0
I'm obviously biased
, but as an editor at a selective journal, I'm not sure whether tighter screening and desk rejections really turns authors off submitting. If they have a high-quality paper, they want it published with other high-quality peer papers. What turns them off is very long TATs.
25.02.2026 12:08 —
👍 1
🔁 0
💬 1
📌 0
Also, I wouldn't rate longer reports and longer replies as a positive outcome...
24.02.2026 13:30 —
👍 1
🔁 0
💬 1
📌 0
Loved this week's episode; never a good sign if your surgeon says yikes... Also wondering whether John Tothill was in one of our malaria challenge papers.
24.02.2026 10:41 —
👍 1
🔁 0
💬 0
📌 0
Reading peer review reports: Reviewer 2 saying I LOVE THIS, BRAVO in all caps. My heart ❤️😊🥲
23.02.2026 10:50 —
👍 5
🔁 0
💬 0
📌 0
What annoys me is if protocols are heavily redacted because of commercial or competition concerns. Ok, don't want to publish everything in appendix but at least need transparency for editorial assessment and peer review.
Rant over 😉
22.02.2026 13:17 —
👍 0
🔁 0
💬 1
📌 0
For clinical trials, we check protocols before publication. Can be complex though, eg if there's protocol changes, trials are registered in more than one registry, or protocols are not in English (we ask for translation or editorial colleague who knows language check, love diverse Lancet team).
22.02.2026 13:17 —
👍 1
🔁 0
💬 1
📌 0
Exactly. Issued when there are concerns warranting further investigation (usually by institution). What happens afterwards depends on findings. Correction, retraction, no action. For last, I would like to see note to say investigated and resolved. Doesn't always happen.
22.02.2026 13:17 —
👍 0
🔁 0
💬 1
📌 0
Exactly. That and how much strain regular stuff such as commuting or being 'on' in an office for a traditional workday can put on disabled people. It's a shame that much of the progress in flexible working is being rolled back.
22.02.2026 12:51 —
👍 3
🔁 0
💬 0
📌 0
A potential late sequelae of measles after normal recovery.
Occurs in ~ 2/10,000. Fatal.
www.nejm.org/doi/full/10.... @nejm.org today
21.02.2026 14:48 —
👍 193
🔁 77
💬 6
📌 4
New Documents Reveal a Controversial Vaccine Study's Unusual Path to CDC Approval
A new investigation has found irregularities in the ethics review of a grant to study effects of a birth dose of hepatitis B vaccine in Guinea-Bissau.
🧪 #ResearchEthics
Appalling Guinea Bissau #hepB #vaccine trial
„an international ethics fiasco[…]
„…CDC appointees allied with Kennedy circumvented critical scientific and ethical safeguards…„
Kudos to investigative journalist @katherineeban.bsky.social
www.rollingstone.com/politics/pol...
21.02.2026 05:25 —
👍 25
🔁 15
💬 1
📌 0
Panel A shows the cumulative incidence of regimen failure (the primary outcome), which was defined as the earliest occurrence of either virologic failure or permanent discontinuation of the trial treatment. Also shown is the cumulative incidence of virologic failure, treatment-related failure (defined as the earliest occurrence of virologic failure or premature treatment discontinuation due to treatment-related adverse events), and permanent discontinuation (key secondary outcomes). Panel B shows the times to regimen failure and virologic failure in step 2. The week 48 visit was performed within a prespecified window (>42 to 50 weeks after randomization). CI denotes confidence interval.
Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges
Aadia Rana & co for the ACTG A5359 LATITUDE Trial Team
Monthly cabotegravir–rilpivirine were superior to standard ART in reducing failure among PWH who had adherence challenges
www.nejm.org/doi/full/10.... #IDSky #HIVSky
19.02.2026 13:33 —
👍 10
🔁 3
💬 0
📌 0
Zing, virus taxonomy wars continue. Language stickler in me welcomes the zeal for order and correctness. Although, if one were very strict that acknowledgement heading should maybe be renamed as conflicts of interest...
20.02.2026 10:33 —
👍 1
🔁 0
💬 0
📌 0
Fluffy tabby cat sitting on a bed, head half turned backwards towards camera, looking accusingly
Side eye from a resentful cat. Tonight's atrocities will not be forgiven. Humans left to go to a sea shanty concert each assuming the other one had already fed the cat. Barely escaped starvation.
19.02.2026 21:28 —
👍 2
🔁 0
💬 0
📌 0
Everyone can easily find our email, there really is no priority access. If you do decide to send a presub, then at least please include an abstract, full paper if you already have it.
19.02.2026 21:22 —
👍 1
🔁 0
💬 0
📌 0
Single vaccine could protect against all coughs, colds and flus, researchers say
A Stanford University team have tested their nasal spray vaccine in animals but still need to do human clinical trials.
Single vaccine could protect against all coughs, colds and flus, researchers say
In mice, this ex-researcher says
Also, I would volunteer to have my immune system put on "high alert" for months
19.02.2026 21:15 —
👍 1
🔁 0
💬 1
📌 0
Maybe. But gosh, that's a relief.
18.02.2026 16:28 —
👍 1
🔁 0
💬 0
📌 0
Reading the letters of your ID successes for our anniversary issue later this year are my highlight of the day, wish I could accept all of them 💜
16.02.2026 08:39 —
👍 2
🔁 0
💬 0
📌 0
I worked at WHO: the USA leaving will not make America healthier
On Jan 30, 2020, WHO declared COVID-19 a Public Health Emergency of International
Concern (PHEIC), the highest alarm it can sound, which is used for moments when the
world must act together or risk ca...
🆕 I had the honor of working at WHO during the COVID-19 & mpox PHEICs.
In my comment for Lancet ID, I explain why global coordination is critical & offer an inside view of what the US is walking away from.
Pathogens have no borders. In public health time is vital
www.thelancet.com/journals/lan...
14.02.2026 18:59 —
👍 93
🔁 28
💬 3
📌 1
I really don't understand why the US is just binning mRNA vaccines. Besides public health (which we know they don't care about), could they at least look at the money? It's a billion dollar market and expected to grow substantially over the next couple years. Alas, not anymore...
13.02.2026 10:36 —
👍 1
🔁 0
💬 0
📌 0
February cover of The Lancet Microbe
Our February issue is now online:
www.thelancet.com/journals/lan...
Our journal is #OpenAccess, so you are free to explore all of our content. But these hashtags offer a flavour: #Klebsiella #AMR #malaria #dermatophytosis #trichuriasis #gonorrhoea #meningitis #tuberculosis
#IDSky #ClinMicro #OA
13.02.2026 09:00 —
👍 1
🔁 2
💬 1
📌 1
A newborn baby being examined at the Simao Mendez central hospital in Bissau. Copyright: Giacomo Pirozzi/Panos Pictures.
"...randomly assigning newborns to not receive the vaccine denies a safe and life-saving intervention to infants in Guinea-Bissau."
New World Report by Gilbert Nakweya ⤵️ spkl.io/63325AsFTL
09.02.2026 13:03 —
👍 15
🔁 8
💬 0
📌 2